Petco Health & Wellness Company, Inc. — fact timeline

Petco Health & Wellness Company, Inc. updated its fiscal year 2026 guidance (reaffirmed).

“The company reaffirmed its full year 2026 net sales and EBITDA outlook and provided its outlook for the second quarter of 2026.”

Petco Health & Wellness Company, Inc. reported the quarter ended May 2, 2026 results: revenue $1.5 billion, net income Net loss of $15.1 million.

“Net sales of $1.5 billion increased 0.2%; comparable sales increased 0.7%.”

Petco Health & Wellness Company, Inc. reported quarter and year ended January 31, 2026 results: revenue $1.5 billion, net income Net loss of $2.6 million.

“our strategic initiatives and assumes a return to positive comps in 2026.” Q4 2025 Overview For the fourth quarter of 2025 compared to the fourth quarter of 2024: • Net sales of $1.5 billion decreased 2.4%; comparable sales decreased 1.6%. • Gross profit decreased 1.4% to $580.8 million and gross margin increased 37 basis points to 38.3%. • Operating income increased”

Petco Health & Wellness Company, Inc. incurred senior notes.

“On February 2, 2026, the Company issued the Notes pursuant to an indenture, dated as of February 2, 2026 (the “Indenture”), among the Company, the guarantors party thereto, and U.S. Bank Trust Company, National Association, as trustee and collateral agent.”

Petco Health & Wellness Company, Inc. amended Second Amendment to Credit Agreement with Citibank, N.A., as Administrative Agent and the 2026 Term Loan Lenders valued at $900 million (effective 2026-02-02).

“entered into the Second Amendment to Credit Agreement (the “Amendment”), amending the First Lien Credit Agreement, dated as of March 4, 2021, by and among the Company, the lenders from time to time party thereto and the Administrative Agent (the “Credit Agreement”). Among other changes, the Amendment provides that the Refinancing Lenders will provide term loans (the “Refinancing Term Loans”) to the Company in an aggregate principal amount of $900 million”

Christy Lake resigned as Director at Petco Health & Wellness Company, Inc..

“On May 19, 2025, Christy Lake resigned from the Board of Directors (the “Board”) of Petco Health and Wellness Company, Inc. (the “Company”) and its compensation committee, effective as of the election of directors at the Company’s 2025 Annual Meeting of Stockholders (the “Annual Meeting”).”

Sabrina Simmons was appointed as Chief Financial Officer at Petco Health & Wellness Company, Inc..

“Sabrina Simmons succeeded Brian LaRose as the Company’s Chief Financial Officer (the “CFO Succession”), effective as of February 17, 2025”

Brian LaRose departed as Chief Financial Officer at Petco Health & Wellness Company, Inc..

“Sabrina Simmons succeeded Brian LaRose as the Company’s Chief Financial Officer (the “CFO Succession”), effective as of February 17, 2025”

Sabrina Simmons resigned as Director at Petco Health & Wellness Company, Inc..

“Ms. Simmons resigned from the Board”

Brian LaRose departed as Chief Financial Officer at Petco Health & Wellness Company, Inc..

“Mr. LaRose became a full-time non-officer employee of the Company, and is expected to remain employed for a transition period ending on April 30, 2025.”

Sabrina Simmons was appointed as Chief Financial Officer at Petco Health & Wellness Company, Inc..

“appointed Sabrina Simmons to succeed Brian LaRose as the Company’s Chief Financial Officer (the “CFO Succession”), effective as of February 17, 2025”

Joel D. Anderson was appointed as Chief Executive Officer at Petco Health & Wellness Company, Inc..

“On July 29, 2024 (the “Transition Date”), Joel D. Anderson succeeded R. Michael Mohan, interim Chief Executive Officer of Petco Health and Wellness Company, Inc. (the “Company”), as the Chief Executive Officer of the Company.”

R. Michael Mohan departed as interim Chief Executive Officer at Petco Health & Wellness Company, Inc..

“On July 29, 2024 (the “Transition Date”), Joel D. Anderson succeeded R. Michael Mohan, interim Chief Executive Officer of Petco Health and Wellness Company, Inc. (the “Company”), as the Chief Executive Officer of the Company.”

Joel D. Anderson was appointed as Director at Petco Health & Wellness Company, Inc..

“Mr. Anderson was appointed as a member of the Board to fill such vacancy”

R. Michael Mohan departed as Interim Chief Executive Officer at Petco Health & Wellness Company, Inc..

“appointed Joel D. Anderson to succeed R. Michael Mohan, interim Chief Executive Officer, as the Chief Executive Officer of the Company”

Joel D. Anderson was appointed as Chief Executive Officer at Petco Health & Wellness Company, Inc..

“appointed Joel D. Anderson to succeed R. Michael Mohan, interim Chief Executive Officer, as the Chief Executive Officer of the Company (the “CEO Succession”), effective as of July 29, 2024”

Amy College was terminated as Chief Merchandising and Supply Chain Officer at Petco Health & Wellness Company, Inc..

“In addition, on May 28, 2024, the Board further approved the termination of Amy College’s role as the Company’s Chief Merchandising and Supply Chain Officer, effective as of such time.”

Justin Tichy resigned as Chief Operating Officer at Petco Health & Wellness Company, Inc..

“On May 28, 2024, Justin Tichy notified Petco Health and Wellness Company, Inc. (the “Company”) of his resignation from his position as Chief Operating Officer of the Company, effective June 8, 2024.”

Petco Health & Wellness Company, Inc. entered into Stock Purchase Agreement with GSSB Corporation, an Ontario corporation of which Glenn Murphy is the sole stockholder, and Scooby Aggregator, LP valued at $2,500,001.30 (effective 2024-05-13).

“On May 13, 2024, Petco Health and Wellness Company, Inc. (the “Company”), GSSB Corporation, an Ontario corporation of which Glenn Murphy is the sole stockholder, and Scooby Aggregator, LP, a Delaware limited partnership, entered into a stock purchase agreement (the “Stock Purchase Agreement”) pursuant to which GSSB Corporation purchased 1,470,589 shares (the “Purchased Shares”) of Class A Common Stock, par value $0.001 per share (“Common Stock”), of the Company in a private placement at a price per share equal to $1.70 for a total of $2,500,001.30.”

Glenn Murphy was appointed as Executive Chairman at Petco Health & Wellness Company, Inc..

“The Board appointed Glenn Murphy as Executive Chairman of the Board, effective May 14, 2024”

Darren MacDonald was terminated as Chief Customer Officer at Petco Health & Wellness Company, Inc..

“On April 4, 2024, the Board of Directors (the “Board”) of Petco Health and Wellness Company, Inc. (the “Company”) approved the termination of employment of Darren MacDonald, the Company’s Chief Customer Officer, effective as of April 12, 2024”

Petco Health & Wellness Company, Inc. reported fourth quarter and full year 2023 results: revenue $1.7 billion, net income GAAP net loss of $22.6 million or $(0.08) per share, EPS $(0.08) per share.

“FOR IMMEDIATE RELEASE: March 13, 2024 Petco Health + Wellness Company, Inc. Reports Fourth Quarter and Full Year 2023 Earnings Q4 2023 Highlights • Net revenue of $1.7 billion increased 6.1 percent year over year including the 14 th week • Comparable sales declined 0.9 percent year over year and increased 4.4 percent on a two-year basis • GAAP net loss”

Ronald V. Coughlin, Jr. departed as Chief Executive Officer, Chairman and member of the Board at Petco Health & Wellness Company, Inc..

“Ronald V. Coughlin, Jr., whose role as the Company’s Chief Executive Officer, Chairman and member of the Board ended effective March 12, 2024.”

Petco Health & Wellness Company, Inc. reported quarter ended October 28, 2023 results: revenue $1.49 billion, net income $(1.2 billion), or $(4.63) per share, EPS $(4.63) per share.

“Company, Inc. Reports Third Quarter Earnings Q3 2023 Operating Results • Comparable sales flat year-over-year and increased 4.1 percent on a two-year basis • Net revenue of $1.49 billion decreased 0.5 percent year-over-year • GAAP net loss of $1.2 billion, or $(4.63) per share, reflecting a $1.2 billion non-cash goodwill impairment charge associated with goodwill”

Petco Health & Wellness Company, Inc. reported the quarter ended July 29, 2023 results: revenue $1.53 billion, net income Net loss of $14.6 million, or $(0.05) per share.

“• Comparable sales grew 3.2 percent year-over-year and 7.0 percent on a two-year basis, resulting in the 19 th consecutive quarter of comparable sales growth • Net revenue of $1.53 billion increased 3.4 percent year-over-year • Net loss of $14.6 million, or $(0.05) per share compared to net income of $13.5 million, or $0.05 per share in the prior year • Adjusted”

David Lubek was appointed as Class II Director at Petco Health & Wellness Company, Inc..

“on June 29, 2023, the Board appointed David Lubek as a Class II director to hold office until the next election of Class II directors and until his successor shall have been duly elected and qualified or until his earlier death, resignation, removal, retirement, or disqualification.”

Iris Yen was appointed as Class I Director at Petco Health & Wellness Company, Inc..

“on June 29, 2023, the Board appointed Iris Yen as an independent Class I director to hold office until the next election of Class I directors and until her successor shall have been duly elected and qualified or until her earlier death, resignation, removal, retirement, or disqualification.”

Maximilian Biagosch resigned as Director at Petco Health & Wellness Company, Inc..

“Also on June 23, 2023, Maximilian Biagosch provided notice to the Board of his intent to resign from the Board, effective June 29, 2023.”

Jennifer Pereira resigned as Director at Petco Health & Wellness Company, Inc..

“On June 23, 2023, Jennifer Pereira resigned from the Board of Directors (the “Board”) of Petco Health and Wellness Company, Inc. (the “Company”), effective immediately.”

Petco Health & Wellness Company, Inc.: Stockholders approved amendment to Article XI of the Second Amended and Restated Certificate of Incorporation to eliminate monetary liability of certain officers in certain circumstances as permitted by Delaware law (effective 2023-06-22).

“On June 22, 2023, at the Annual Meeting, upon the recommendation of the Board, the Company’s stockholders approved amendments to Article XI of the Company’s Second Amended and Restated Certificate of Incorporation (the “Certificate”) to provide for the elimination of monetary liability of certain officers of the company in certain circumstances as is or may be permitted under Delaware law (the “Amendment”).”

Petco Health & Wellness Company, Inc. shareholders approved Ratification of Ernst & Young LLP as independent auditor for fiscal year ending February 3, 2024 at the 2024-02-03 meeting.

“5. The ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending February 3, 2024 (Proposal 5): Votes For Votes Against Abstentions Broker Non-Votes 256,717,516 145,665 75,780 N/A”

Petco Health & Wellness Company, Inc. shareholders approved Approval of Amendment to limit liability of certain officers as permitted by Delaware law.

“4. The approval of the Amendment to limit the liability of certain officers as permitted by Delaware law (Proposal 4): Votes For Votes Against Abstentions Broker Non-Votes 198,915,189 46,911,567 65,935 11,046,270”

Petco Health & Wellness Company, Inc. shareholders approved Approval of Plan Amendment to increase shares authorized under the 2021 Plan.

“3. The approval of the Plan Amendment to increase the number of shares of Class A Common Stock authorized for issuance under the 2021 Plan (Proposal 3): Votes For Votes Against Abstentions Broker Non-Votes 219,369,606 26,481,478 41,607 11,046,270”

Petco Health & Wellness Company, Inc. shareholders approved Non-binding advisory vote on executive compensation.

“2. The approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers (Proposal 2): Votes For Votes Against Abstentions Broker Non-Votes 187,027,131 58,773,041 92,519 11,046,270”

Petco Health & Wellness Company, Inc. shareholders approved Election of Gary Briggs, Nishad Chande, and Mary Sullivan as Class III directors.

“1. The election of the Director Nominees to the Board as Class III directors (Proposal 1): Director Nominee Votes For Votes Withheld Broker Non-Votes Gary Briggs 206,685,215 39,207,476 11,046,270 Nishad Chande 221,142,972 24,749,719 11,046,270 Mary Sullivan 207,311,021 38,581,670 11,046,270”

Petco Health & Wellness Company, Inc. reported first quarter of fiscal 2023 results: revenue $1.56 billion, net income Net loss of $1.9 million, EPS $(0.01) per diluted share. Guidance reaffirmed.

“• Comparable sales grew 5.1 percent year-over-year and 10.2 percent on a two-year basis, resulting in the 18 th consecutive quarter of comparable sales growth • Net revenue of $1.56 billion increased 5.4 percent year-over-year • Net loss of $1.9 million, or $(0.01) per diluted share compared to net income of $24.7 million, or $0.09 per diluted share in the prior”

Petco Health & Wellness Company, Inc. reported the quarter ended April 29, 2023 results: revenue $1.56 billion, net income $1.9 million, EPS $(0.01) per diluted share. Guidance reaffirmed.

“• Comparable sales grew 5.1 percent year-over-year and 10.2 percent on a two-year basis, resulting in the 18 th consecutive quarter of comparable sales growth • Net revenue of $1.56 billion increased 5.4 percent year-over-year • Net loss of $1.9 million, or $(0.01) per diluted share compared to net income of $24.7 million, or $0.09 per diluted share in the prior”

Petco Health & Wellness Company, Inc. reported the fiscal year ended January 28, 2023 results: revenue $6.04 billion, net income $90.8 million, EPS $0.34 per share. Guidance initiated.

“For the full year 2022, Petco delivered net revenue of $6.04 billion, up 3.9 percent versus prior year. Revenue growth was driven by strength in the company’s consumables business, up 12.9 percent versus prior year, and services and other business, up 20.2 percent versus prior year, and partially offset by its supplies and companion animal business, down 8.9 percent versus prior year. Net income was $90.8 million or $0.34 per share, compared to $164.4 million or $0.62 per share in the prior year.”

Petco Health & Wellness Company, Inc. reported the quarter ended January 28, 2023 results: revenue $1.58 billion, net income $32.7 million, EPS $0.12 per share. Guidance initiated.

“In the fourth quarter of 2022, Petco delivered net revenue of $1.58 billion, up 4.2 percent versus prior year, driven by strength in the company’s consumables business, up 12.1 percent versus prior year, and services and other business, up 17.0 percent versus prior year, which was partially offset by its supplies and companion animal business, down 7.8 percent versus prior year. Net income was $32.7 million or $0.12 per share, compared to $29.0 million or $0.11 per share in the prior year.”

Petco Health & Wellness Company, Inc. amended revolving credit with Citibank, N.A., as administrative agent at replace the LIBOR-based interest rate applicable to borrowings under the ABL Cre.

“On December 12, 2022, the Company entered into a first amendment to ABL revolving credit agreement (the “ABL Amendment”) with Citibank, N.A., as administrative agent (in such capacity, the “ABL Administrative Agent”), which amends the ABL revolving credit agreement, dated March 4, 2021, by and among the Company, the ABL Administrative Agent and the lenders named therein (as so amended, the “ABL Credit Agreement”). Pursuant to the terms of the ABL Amendment, the ABL Administrative Agent agreed to replace the LIBOR-based interest rate applicable to borrowings under the ABL Credit Agreement with a SOFR-based interest rate, subject to adjustment as specified in the ABL Amendment.”

Petco Health & Wellness Company, Inc. amended credit facility with Citibank, N.A., as administrative agent at replace the LIBOR-based interest rate applicable to borrowings under the First L.

“On December 12, 2022, Petco Health and Wellness Company, Inc. (the “Company”) entered into a first amendment to credit agreement (the “First Lien Amendment”) with Citibank, N.A., as administrative agent (in such capacity, the “First Lien Administrative Agent”), which amends the first lien credit agreement, dated March 4, 2021, by and among the Company, the First Lien Administrative Agent and the lenders named therein (as so amended, the “First Lien Credit Agreement”). Pursuant to the terms of the First Lien Amendment, the First Lien Administrative Agent agreed to replace the LIBOR-based interest rate applicable to borrowings under the First Lien Credit Agreement with a SOFR-based interest rate, subject to adjustment as specified in the First Lien Amendment.”

Petco Health & Wellness Company, Inc. amended ABL Credit Agreement with Citibank, N.A. valued at Replaced LIBOR-based interest rate with SOFR-based interest rate (effective 2022-12-12).

“On December 12, 2022, the Company entered into a first amendment to ABL revolving credit agreement (the “ABL Amendment”) with Citibank, N.A., as administrative agent (in such capacity, the “ABL Administrative Agent”), which amends the ABL revolving credit agreement, dated March 4, 2021, by and among the Company, the ABL Administrative Agent and the lenders named therein (as so amended, the “ABL Credit Agreement”). Pursuant to the terms of the ABL Amendment, the ABL Administrative Agent agreed to replace the LIBOR-based interest rate applicable to borrowings under the ABL Credit Agreement with a SOFR-based interest rate, subject to adjustment as specified in the ABL Amendment. The foregoing description of the terms of the ABL Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the ABL Amendment, a copy of which is filed as Exhibit 10.2 and incorporated by reference into this Item 1.01.”

Petco Health & Wellness Company, Inc. amended First Lien Credit Agreement with Citibank, N.A. valued at Replaced LIBOR-based interest rate with SOFR-based interest rate (effective 2022-12-12).

“On December 12, 2022, Petco Health and Wellness Company, Inc. (the “Company”) entered into a first amendment to credit agreement (the “First Lien Amendment”) with Citibank, N.A., as administrative agent (in such capacity, the “First Lien Administrative Agent”), which amends the first lien credit agreement, dated March 4, 2021, by and among the Company, the First Lien Administrative Agent and the lenders named therein (as so amended, the “First Lien Credit Agreement”). Pursuant to the terms of the First Lien Amendment, the First Lien Administrative Agent agreed to replace the LIBOR-based interest rate applicable to borrowings under the First Lien Credit Agreement with a SOFR-based interest rate, subject to adjustment as specified in the First Lien Amendment. The foregoing description of the terms of the First Lien Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the First Lien Amendment, a copy of which is filed as Exhibit 1”

Petco Health & Wellness Company, Inc. reported fiscal year 2022 results: revenue $5.975 billion to $6.05 billion, EPS $0.75 to $0.79 per share. Guidance reaffirmed.

“Reaffirms full year guidance for net revenue of $5.975 billion to $6.05 billion and Adjusted EBITDA 1 of $580.0 million to $595.0 million; Updates full year guidance for Adjusted Earnings Per Share 1 to between $0.75 and $0.79”

Petco Health & Wellness Company, Inc. reported third quarter ended October 29, 2022 results: revenue $1.50 billion, net income $19.9 million, EPS $0.07 per share.

“In the third quarter of 2022, Petco delivered net revenue of $1.50 billion, up 4.0 percent versus prior year. Net income was $19.9 million or $0.07 per share compared to $52.8 million or $0.20 per share in the prior year.”

Michael Nuzzo departed as other_named_officer at Petco Health & Wellness Company, Inc..

“Mr. Michael Nuzzo left the Company, effective as of August 13, 2022.”

Michael Nuzzo departed as Chief Operating Officer at Petco Health & Wellness Company, Inc..

“Mr. Nuzzo stepped down from his current role on August 8, 2022 and will be leaving the Company, effective as of August 13, 2022.”

Justin Tichy was appointed as Chief Operating Officer at Petco Health & Wellness Company, Inc..

“On August 8, 2022, the Board of Directors (the “Board”) of Petco Health and Wellness Company, Inc. (the “Company”) appointed Justin Tichy to succeed Michael Nuzzo as the Company’s Chief Operating Officer, effective as of August 8, 2022.”

Michael Nuzzo changed role as Executive Vice President, Chief Operating Officer and President of Petco Services at Petco Health & Wellness Company, Inc..

“Mr. Nuzzo will continue to serve as the Company’s Executive Vice President, Chief Operating Officer and President of Petco Services—roles he has held since July 2019.”

Brian LaRose was appointed as Chief Financial Officer at Petco Health & Wellness Company, Inc..

“On August 18, 2021, the Board of Directors (the “Board”) of Petco Health and Wellness Company, Inc. (the “Company”) appointed Brian LaRose to succeed Michael Nuzzo as the Company’s Chief Financial Officer, effective as of August 19, 2021.”